Profhilo vs Skinbooster — Biostimulator Comparison and Right Choice Guide 2026

"Doctor, should I get Profhilo or Skinbooster?" This is one of the most frequently asked comparative questions I've heard in my consultation room in the last three years. The question is not wrong — but the assumption behind the question is wrong: because the patient often thinks of Profhilo as a single product, and Skinbooster as its "alternative." The reality is different. Profhilo is indeed the brand name of a single patented product (IBSA Farmaceutici, Italy); Skinbooster, on the other hand, is not the name of a single product, but a generic category umbrella, under which different molecular structured products such as Restylane Vital, Juvederm Volite, Sunekos, and NCTF 135HA are found. In this guide, I will compare Profhilo with each member of the Skinbooster family separately, and explain which one is clinically more suitable for which patient — considering age, skin structure, area, goal, and combination possibilities — within the framework I have distilled from my 30+ years of medical aesthetic practice. I am a graduate of Ondokuz Mayıs University Faculty of Medicine (ORCID 0009-0007-8058-2774); the clinical statements in the article are my personal observations, and the scientific statements are based on my PubMed-referenced sources.

Profhilo Scientific Basis: Thermal-Stabilization Concept

Profhilo differs from classic hyaluronic acid products in two fundamental aspects: it does not contain a chemical cross-linking agent (BDDE) and it combines two different molecular weights of pure HA with thermal stabilization. These two features directly determine the product's behavior in tissue and its clinical effect profile.

NAHYCO Hybrid Cooperative Complex

Classic HA filler products (Restylane, Juvederm, Belotero) are cross-linked with chemical agents such as BDDE (1,4-butanediol diglycidyl ether); this increases the permanence of the HA gel in the tissue but reduces its diffusion. Profhilo does not contain this agent. Instead, in IBSA Farmaceutici's patented NAHYCO technology, pure HA in a 2 mL syringe is stabilized by a controlled thermal process (30 minutes at 90 degrees). Result: 32 mg high molecular weight HA (H-HA, average 1,100-1,400 kDa) and 32 mg low molecular weight HA (L-HA, average 80-100 kDa) are "cooperatively" bound within a single hybrid gel.

Stellavato et al.'s 2019 study (Polymers 2019;11(11):1819) showed that this hybrid structure increased type-I procollagen synthesis in dermal fibroblasts by 20-30% in vitro. This means Profhilo exhibits not only passive hydration but also active biostimulant behavior.

Bio-Aesthetic Points (BAP) Technique — 5-Point Protocol

Profhilo's clinical uniqueness lies not only in its molecular structure but also in its application technique. The BAP technique defines 5 strategic points on the face: the high point of the zygomatic arch, the anterior border of the masseter, the mandibular angle, the chin base, and the preauricular region. 0.2 mL of product (1 mL for the entire face) is administered at each point, not at the supraperiosteal level, but at the deep dermal level. Since there is no cross-linking, the product spreads from the 5 points within 24-48 hours, forming a "net" on the face. Separate BAP-N (Bio-Aesthetic Points for Neck) 5 points have been defined for the neck.

Beleznay et al.'s 2017 study (J Drugs Dermatol 2017;16(11):1107-1112) reported that the BAP technique significantly reduced the risk of late-onset nodule formation compared to the classic linear-threading technique. Bertossi et al.'s 2019 prospective study (Dermatologic Therapy 2019;32(6):e13093) showed that the 60-day BAP protocol provided measurable skin elasticity improvement.

Indication Framework

Profhilo is positioned as the first-choice biostimulant for patients aged 35-65 who show clinical signs of dermal thinning and loss of elasticity, but do not yet have significant volume loss. It can be applied to the face, neck, décolleté, and back of the hands — all four areas; this comprehensiveness is a difference from most products in the Skinbooster category. For detailed molecular information, please read the hyaluronic acid glossary entry and the biostimulator definition.

Skinbooster Family: Restylane Vital + Juvederm Volite + NCTF + Sunekos

Although the term "Skinbooster" is often associated with Galderma's Restylane Vital product in the market — in common clinical language in Turkey, at least 4 different products are discussed under the "skinbooster" umbrella. Each has different active ingredients, viscosity, cross-linking structure, and clinical goals. Comparing it with Profhilo without separating these subcategories is misleading.

Restylane Vital (Galderma) — NASHA Skin Booster

Restylane Vital is a "softened" version of Galderma's NASHA (Non-Animal Stabilized Hyaluronic Acid) technology. It contains 20 mg/mL stabilized HA (Vital Light: 12 mg/mL). Unlike classic Restylane filler, it has much smaller HA particles and low cross-linking density. Cassuto and Sundaram's 2013 study (Plast Reconstr Surg 2013;132(4 Suppl 2):48S-58S) reports objective improvement in skin hydration parameters after 36 weeks of follow-up. Application technique: superficial papule technique or micro-bolus; depth 1.5-2.5 mm. Standard protocol: 3 sessions × 4 weeks apart; maintenance every 4-6 months with a single session.

Juvederm Volite (Allergan/AbbVie) — VYCROSS Skin Booster

Volite is Allergan's product that brings the VYCROSS HA platform to the skin booster category. It contains 12 mg/mL HA + 0.3% lidocaine; the VYCROSS system cross-links low (90%) low molecular weight HA + high (10%) high molecular weight HA at a patented ratio. Niforos et al.'s 2017 study (Dermatol Surg 2017;43(10):1271-1280) reports that Volite showed an effect duration of up to 9 months with a single session. This point is the most visible difference from Restylane Vital. Application: micro-bolus 2-3 mm; standard protocol 1 session + maintenance every 6-9 months.

NCTF 135HA (Filorga) — Polyrevitalizing Mesococktail

NCTF 135HA (Laboratoires Filorga, France) is not a pure HA product; it is a 55-component polyrevitalizing formulation: it contains 12 vitamins, 23 amino acids, 6 coenzymes, 6 minerals, 5 nucleobases, and 2 antioxidants. HA concentration is 5 mg/mL; application is done with mesotherapy technique to the papillary dermis (0.8-1.5 mm). Lacarrubba et al.'s 2016 study (J Cosmet Dermatol 2016;15(1):28-33) showed that NCTF demonstrated significant improvement in the subepidermal low-echoic band in ultrasonographic dermal change measurement. Standard protocol: 4 sessions × 2-3 weeks apart; maintenance once a month.

Sunekos (Professional Aesthetics) — HA + Patented 6 Amino Acids

Sunekos is a patented HA + 6 amino acid (glycine, L-proline, L-lysine, L-leucine, L-valine, L-alanine) complex from the Italian firm Professional Aesthetics. It claims to directly target elastic fiber synthesis (Sparavigna et al., 2019, Aesthet Surg J Open Forum 2019;1(2):ojz015). Concentration 12 mg/mL HA + amino acid matrix; application meso or micro-papule technique; depth 1-2 mm. Standard protocol: 4 sessions × 7-10 days apart (intensive start) or 3 sessions × 3 weeks apart.

The common feature of these four products: none of them reach Profhilo's 32+32 mg pure HA hybrid density, none of them are applied with a BAP-like 5-point systematic technique, and none of them are in the same clinical category as Profhilo's bio-remodeling claim. For a detailed brand comparison, I recommend reading this article together with the Youth Vaccine Brands Guide.

Mechanism Comparison: Profhilo Full Spread Biostimulation vs Skinbooster Hydration-Focused

The difference in mechanism between the two categories is the origin of the difference in clinical effect. Although Profhilo and Skinbooster products are grouped under the "hyaluronic acid" umbrella, their behavior in tissue is distinctly different.

Profhilo: No Cross-Link → Full Spread → Biostimulation

Profhilo's clinical uniqueness comes from not containing BDDE. Once administered into the dermis, H-HA and L-HA remain together with "cooperative" bonds but spread rapidly in the tissue. The injection starting from 5 points provides a net-like diffusion to the entire face within 24-48 hours. L-HA directly stimulates fibroblasts (CD44 receptor), increasing type-I and type-III collagen + elastin synthesis. H-HA also provides hydration and antioxidant mediation. Stellavato's 2019 study showed that this hybrid activity produced a superior biostimulant effect compared to H-HA alone or L-HA alone. Clinical equivalent: skin tightening, tissue quality, and elasticity improvement.

Skinbooster Family: Light Cross-Link → Hydration-Focused

Restylane Vital and Volite contain cross-links, albeit at low density; this prevents the product from spreading completely in the tissue, instead creating dermal micro-deposits (micro-bolus). These micro-deposits slowly release HA and create hydration, radiance, and softening of fine lines in the skin. NCTF, since it has no cross-links, spreads but its HA concentration (5 mg/mL) is very low; the effect comes not from HA but from the additional 55 components (vitamins, amino acids, coenzymes). Sunekos, on the other hand, works on elastin synthesis with HA + amino acids based on conviction. None of them have Profhilo's combined H-HA/L-HA biostimulant effect. Therefore, the clinical outcome expectation is different: skinbooster products emphasize skin radiance and moisture; tightening is secondary or minimal.

Thermodynamic vs Chemical Stabilization Difference

Profhilo's thermal stabilization offers two advantages compared to chemical cross-linking: (1) the risk of allergic and hypersensitivity reactions is lower (BDDE-dependent late-onset nodule risk cannot be completely excluded); (2) lump (granule) formation is very rare due to full diffusion in the tissue. The BDDE or VYCROSS-based stabilization of Skinbooster products leads to the product remaining more localized in the tissue — this is both an advantage (long-lasting effect) and a disadvantage (risk of late nodules). Beleznay's 2017 study documented the risk of late-onset papules with VYCROSS-based Volite.

Protocol Differences: Profhilo 2 Sessions × BAP vs Skinbooster 3-4 Sessions Meso

The number of treatments, intervals, and total product amount; there are significant differences between the application protocols of the two categories. This difference is important not only practically (time + cost) but also clinically (effect accumulation process).

Profhilo Standard Protocol

Profhilo's clinical developers (Cavallini et al., Sparavigna et al., Bertossi et al.) consistently recommend 2 sessions as standard: day 0 and day 30. Each session is 1 syringe (2 mL); it is administered at 10 points (5 on the face + 5 on the neck or only 5 on the face) at the sub-supraperiosteal dermal level using the BAP technique. Total protocol: 4 mL Profhilo within 2 months. The first significant visual change after 4-6 weeks; peak effect 60-90 days. Effect duration 6-9 months; a single session (1 syringe) every 6 months is sufficient for maintenance. The "economy" advantage of this protocol is long-interval maintenance with few sessions.

Skinbooster Standard Protocols

The protocol for products in the Skinbooster family is more "meso-style" — more frequent initial sessions + more frequent maintenance:

• Restylane Vital: 3 sessions × 4 weeks apart (3-month initial) + maintenance every 6 months.
• Juvederm Volite: 1 session + maintenance every 6-9 months (most practical).
• NCTF 135HA: 4 sessions × 2-3 weeks apart (intensive initial 8-10 weeks) + monthly maintenance.
• Sunekos: 4 sessions × 7-10 days apart or 3 sessions × 3 weeks apart.

As can be seen, the only exception is Volite (single-session model); the other three Skinbooster products require 2-4 times more clinic visits compared to Profhilo. This should definitely be discussed during consultation as a practical factor, especially for patients who work intensively, travel frequently, or come from distant cities.

Application Technique Difference

Profhilo BAP technique — fixed, systematic, 5-point protocol. Low operator-dependency (every practitioner should know the same 5 points). Sasaki et al.'s 2018 study (Aesthetic Plast Surg 2018;42(3):635-644) showed that a BAP-like layered systematic approach significantly increased result consistency compared to the classic free-hand technique. Skinbooster products, on the other hand, are mostly administered at multiple points (30-100 points on the face) using mesotherapy or micro-papule technique; operator experience dependency is high, result consistency is moderate.

Clinical Outcome Expectation: Profhilo Tightening vs Skinbooster Radiance + Moisture

The change the patient expects is the most critical criterion for brand selection. Since marketing language groups all these products under the umbrella of "skin rejuvenation," patient disappointment often comes from choosing the wrong product for the wrong indication.

Profhilo Clinical Effect Profile

Profhilo's clinical effect spectrum emerges sequentially at the end of 2 months: (1) first 2-3 weeks — papule resorption and skin hydration sensation; (2) 4-6 weeks — softening of superficial fine lines; (3) 6-9 weeks — measurable improvement in skin firmness and elasticity sensation; (4) 8-12 weeks — slight "lift" sensation in facial contour (especially lower face and jowl area). Bertossi's 2019 study reports a significant increase in the cutometer-measured R0 (skin elasticity) parameter on day 90 compared to baseline. In my clinical practice, the areas that respond most strongly to Profhilo are the lower face (jowl + upper neck) and décolleté; the mid-face responds more quietly.

Skinbooster Clinical Effect Profile

The clinical effect spectrum of the Skinbooster family is different:

• Restylane Vital / Vital Light: Skin hydration, radiance, improvement in the appearance of small pores. Elasticity is secondary. Most common application areas: cheeks, periorbital (Vital Light), décolleté.
• Juvederm Volite: Skin surface quality (smoothness), softening of fine lines, sustainable skin radiance for 6-9 months with a single session. Most common: lower face, perioral, back of hands.
• NCTF 135HA: "Mesotherapy effect" — skin radiance, reduction of dullness, micro-matte appearance. Especially suitable for smoker/UV-fatigued skin thanks to multi-factorial nutrient support. Most common: entire face + neck.
• Sunekos: Periorbital and perioral elastic fiber improvement, smoothing of fine wrinkles. Most common: lower eyelid, perioral.

The common feature of these four products: none of them reach Profhilo's 32+32 mg pure HA hybrid density, none of them are applied with a BAP-like 5-point systematic technique, and none of them are in the same clinical category as Profhilo's bio-remodeling claim. For a detailed brand comparison, I recommend reading this article together with the Youth Vaccine Brands Guide.

Mechanism Comparison: Profhilo Full Spread Biostimulation vs Skinbooster Hydration-Focused

The difference in mechanism between the two categories is the origin of the difference in clinical effect. Although Profhilo and Skinbooster products are grouped under the "hyaluronic acid" umbrella, their behavior in tissue is distinctly different.

Profhilo: No Cross-Link → Full Spread → Biostimulation

Profhilo's clinical uniqueness comes from not containing BDDE. Once administered into the dermis, H-HA and L-HA remain together with "cooperative" bonds but spread rapidly in the tissue. The injection starting from 5 points provides a net-like diffusion to the entire face within 24-48 hours. L-HA directly stimulates fibroblasts (CD44 receptor), increasing type-I and type-III collagen + elastin synthesis. H-HA also provides hydration and antioxidant mediation. Stellavato's 2019 study showed that this hybrid activity produced a superior biostimulant effect compared to H-HA alone or L-HA alone. Clinical equivalent: skin tightening, tissue quality, and elasticity improvement.

Skinbooster Family: Light Cross-Link → Hydration-Focused

Restylane Vital and Volite contain cross-links, albeit at low density; this prevents the product from spreading completely in the tissue, instead creating dermal micro-deposits (micro-bolus). These micro-deposits slowly release HA and create hydration, radiance, and softening of fine lines in the skin. NCTF, since it has no cross-links, spreads but its HA concentration (5 mg/mL) is very low; the effect comes not from HA but from the additional 55 components (vitamins, amino acids, coenzymes). Sunekos, on the other hand, works on elastin synthesis with HA + amino acids based on conviction. None of them have Profhilo's combined H-HA/L-HA biostimulant effect. Therefore, the clinical outcome expectation is different: skinbooster products emphasize skin radiance and moisture; tightening is secondary or minimal.

Thermodynamic vs Chemical Stabilization Difference

Profhilo's thermal stabilization offers two advantages compared to chemical cross-linking: (1) the risk of allergic and hypersensitivity reactions is lower (BDDE-dependent late-onset nodule risk cannot be completely excluded); (2) lump (granule) formation is very rare due to full diffusion in the tissue. The BDDE or VYCROSS-based stabilization of Skinbooster products leads to the product remaining more localized in the tissue — this is both an advantage (long-lasting effect) and a disadvantage (risk of late nodules). Beleznay's 2017 study documented the risk of late-onset papules with VYCROSS-based Volite.

Protocol Differences: Profhilo 2 Sessions × BAP vs Skinbooster 3-4 Sessions Meso

The number of treatments, intervals, and total product amount; there are significant differences between the application protocols of the two categories. This difference is important not only practically (time + cost) but also clinically (effect accumulation process).

Profhilo Standard Protocol

Profhilo's clinical developers (Cavallini et al., Sparavigna et al., Bertossi et al.) consistently recommend 2 sessions as standard: day 0 and day 30. Each session is 1 syringe (2 mL); it is administered at 10 points (5 on the face + 5 on the neck or only 5 on the face) at the sub-supraperiosteal dermal level using the BAP technique. Total protocol: 4 mL Profhilo within 2 months. The first significant visual change after 4-6 weeks; peak effect 60-90 days. Effect duration 6-9 months; a single session (1 syringe) every 6 months is sufficient for maintenance. The "economy" advantage of this protocol is long-interval maintenance with few sessions.

Skinbooster Standard Protocols

The protocol for products in the Skinbooster family is more "meso-style" — more frequent initial sessions + more frequent maintenance:

• Restylane Vital: 3 sessions × 4 weeks apart (3-month initial) + maintenance every 6 months.
• Juvederm Volite: 1 session + maintenance every 6-9 months (most practical).
• NCTF 135HA: 4 sessions × 2-3 weeks apart (intensive initial 8-10 weeks) + monthly maintenance.
• Sunekos: 4 sessions × 7-10 days apart or 3 sessions × 3 weeks apart.

As can be seen, the only exception is Volite (single-session model); the other three Skinbooster products require 2-4 times more clinic visits compared to Profhilo. This should definitely be discussed during consultation as a practical factor, especially for patients who work intensively, travel frequently, or come from distant cities.

Application Technique Difference

Profhilo BAP technique — fixed, systematic, 5-point protocol. Low operator-dependency (every practitioner should know the same 5 points). Sasaki et al.'s 2018 study (Aesthetic Plast Surg 2018;42(3):635-644) showed that a BAP-like layered systematic approach significantly increased result consistency compared to the classic free-hand technique. Skinbooster products, on the other hand, are mostly administered at multiple points (30-100 points on the face) using mesotherapy or micro-papule technique; operator experience dependency is high, result consistency is moderate.

Clinical Outcome Expectation: Profhilo Tightening vs Skinbooster Radiance + Moisture

The change the patient expects is the most critical criterion for brand selection. Since marketing language groups all these products under the umbrella of "skin rejuvenation," patient disappointment often comes from choosing the wrong product for the wrong indication.

Profhilo Clinical Effect Profile

Profhilo's clinical effect spectrum emerges sequentially at the end of 2 months: (1) first 2-3 weeks — papule resorption and skin hydration sensation; (2) 4-6 weeks — softening of superficial fine lines; (3) 6-9 weeks — measurable improvement in skin firmness and elasticity sensation; (4) 8-12 weeks — slight "lift" sensation in facial contour (especially lower face and jowl area). Bertossi's 2019 study reports a significant increase in the cutometer-measured R0 (skin elasticity) parameter on day 90 compared to baseline. In my clinical practice, the areas that respond most strongly to Profhilo are the lower face (jowl + upper neck) and décolleté; the mid-face responds more quietly.

Skinbooster Clinical Effect Profile

The clinical effect spectrum of the Skinbooster family is different:

• Restylane Vital / Vital Light: Skin hydration, radiance, improvement in the appearance of small pores. Elasticity is secondary. Most common application areas: cheeks, periorbital (Vital Light), décolleté.
• Juvederm Volite: Skin surface quality (smoothness), softening of fine lines, sustainable skin radiance for 6-9 months with a single session. Most common: lower face, perioral, back of hands.
• NCTF 135HA: "Mesotherapy effect" — skin radiance, reduction of dullness, micro-matte appearance. Multi-factorial nutrient support makes it especially suitable for smoker/UV-fatigued skin. Most common: entire face + neck.
• Sunekos: Periorbital and perioral elastic fiber improvement, smoothing of fine wrinkles. Most common: lower eyelid, perioral.

Patient Satisfaction Factor

The general trend I observe in my clinical practice: if dermal dryness + dullness is dominant in patients aged 35-45, satisfaction with the Skinbooster family is high; if loss of elasticity + early sagging is dominant in patients aged 40-55, satisfaction with Profhilo is high. If patients are 50+ and have significant sagging, neither Profhilo nor Skinbooster alone is sufficient; a combination (HIFU + RFM + Profhilo) is needed. For details, see the Layered Lifting Guide.

8-Dimensional Comparison Table

The table below is the written version of the comparison framework I often draw on a whiteboard for patients during consultation. For the Skinbooster column, I have based it on Restylane Vital, the most common representative of this family; I will provide additional parentheses for Volite, NCTF, and Sunekos.

Dimension	Profhilo	Skinbooster (Restylane Vital base)
HA Concentration	32 mg H-HA + 32 mg L-HA (total 32 mg/mL); no BDDE	20 mg/mL stabilized HA (Volite 12 mg/mL; Sunekos 12 mg/mL + amino acids; NCTF 5 mg/mL + 55 components)
Application Technique	BAP 5 points (systematic, sub-supraperiosteal)	Micro-papule / meso (30-100 points, dermal 1.5-2.5 mm)
Number of Sessions	2 sessions × 30 days apart + maintenance every 6 months	3 sessions × 4 weeks (Vital), 1 session (Volite), 4 sessions (NCTF/Sunekos)
Clinical Effect	Skin tightening + elasticity + biostimulation	Hydration + radiance + glow (secondary tightening)
Price Range (TTB-safe)	Per session / per syringe; total protocol cost including maintenance is evaluated	Cumulative cost may be similar to or higher than Profhilo due to higher number of sessions
Application Location	Face + neck + décolleté + back of hands (4 regions full indication)	Face + décolleté (NCTF/Sunekos additionally lower eye, perioral)
Downtime	24-48 hours — 5 point papules (characteristic); can be covered with makeup after 24 hours	24-72 hours — multiple papules, mild edema, rare bruising
Contraindication	Pregnancy, active infection, active phase of autoimmune disease, isotretinoin in last 6 months	Same + B12/vitamin allergy screening for NCTF; amino acid allergy screening for Sunekos

This table is an initial framework; the final protocol is individualized with physical examination + skin analysis (cutometer / VISIA / Skinspan) + medical history + patient goals and lifestyle assessment. Pricing is shared within a written plan at the clinic, not on the website, in accordance with TTB ethical rules.

Which Patient for Which? Decision Matrix

The following decision matrix is used as a framework for initial recommendations in my clinical practice. You can match the patient profile and see the primary choice + alternative; the final decision is clarified during consultation.

Patient Profile	Primary Choice	Alternative
30-35 years old, dry skin, dullness, preventive	Restylane Vital or NCTF	Volite (single session model)
35-40 years old, loss of radiance, onset of fine lines	Restylane Vital or Volite	Profhilo (if tissue quality is also a target)
40-50 years old, loss of elasticity + early sagging	Profhilo	Profhilo + Volite combination
45-55 years old, onset of jowl + skin dryness	Profhilo	Volite + HIFU layered
Neck + décolleté dominant indication	Profhilo (BAP-N protocol)	Volite
Aging of the back of the hands	Profhilo	Volite
Lower eyelid fine lines + dark circles	NCTF or Sunekos	Restylane Vital Light
Perioral fine lines	Sunekos or NCTF	Volite
Smoking history, photoaging dominant	NCTF (multi-nutrient) → Profhilo maintenance	Sunekos
Frequent travel, few clinic visits	Volite (single session)	Profhilo (2 sessions)
Dark phototype (IV-VI), PIH risk	Profhilo or NCTF (meso-type)	Restylane Vital (careful)

Age alone is not a threshold for me; clinical findings (elasticity, dryness, sagging, pore appearance) and goals (tightening or radiance) are decisive. For a detailed decision framework, see the Skin Longevity scientific guide and the Skin Longevity section.

Combination Strategy: Profhilo for Face + Skinbooster for Neck/Décolleté/Hands

Profhilo and Skinbooster products are often complementary, not rivals. In my clinical practice, I frequently place both categories in different areas within the same patient plan.

"Area Division" Strategy

One of the most common combination protocols I use in my clinical practice is this:

• Face (especially lower face and jowl): Profhilo BAP 5 points — biostimulation + skin tightening.
• Neck: Profhilo BAP-N 5 points or alternatively Volite micro-bolus — chosen according to the area.
• Décolleté: Volite or Restylane Vital micro-papule — targeting superficial wrinkles and hydration.
• Back of hands: Profhilo or Volite (both effective; according to patient preference).
• Lower eye + perioral: Sunekos or NCTF meso — elastic fiber and micro-nutrient support.

The advantage of this multi-area strategy is that the most suitable product for each area is placed, and the total annual protocol avoids single-brand dependency. Sasaki's 2018 study showed that this type of layered / multi-zonal approach increased overall patient satisfaction rates compared to a single-product protocol.

Profhilo + Botox / HIFU / RFM Combinations

Profhilo creates synergy with botox in the same session, and with HIFU or Gold Needle (RFM) in sequential plans. Profhilo provides the skin quality layer, botox addresses mimic lines, and HIFU/RFM provides deep tissue support. Example annual plan: Profhilo 2 sessions + botox in spring; HIFU or RFM 1 session + Profhilo maintenance in autumn. For details on this layered protocol: Layered Lifting.

Early Sagging vs Advanced Dryness: Selection Framework

The most practical key to solving the Profhilo vs Skinbooster dilemma is to correctly identify the patient's clinical findings: are early ptosis signs dominant, or advanced xerosis + dyschromia?

Early Sagging Profile — Profhilo Directed

Signs of early sagging include: (1) softening of the lower face contour (early jowl); (2) impression of "tissue quality decrease" beyond deepening in the nasolabial area; (3) slower skin retraction when "gently pulled" (reduced elasticity — Schade test); (4) early platysmal banding in the neck; (5) loss of sharpness in facial contour compared to old photographs. In this profile, Profhilo's biostimulant effect (fibroblast activation, collagen + elastin synthesis) directly aligns with the clinical goal. The 2-session BAP protocol provides a significant tissue response in 60-90 days. What makes Profhilo the first choice for this profile is its bio-remodeling categorical feature, which is not found in the Skinbooster family.

Advanced Dryness Profile — Skinbooster Directed

The advanced dryness profile is different: (1) a "dull + matte" appearance on the skin surface; (2) intense fine lines but no significant loss of elasticity; (3) an "open" impression of pores; (4) UV-aging lines on the décolleté; (5) inconsistent transparent/dark spot distribution on the skin (mild dyschromia). In this profile, the goal is hydration + radiance + skin surface quality; Restylane Vital, Volite, or NCTF achieve this goal more directly. Profhilo is also effective in this profile, but since the expected outcome is "tightening" not "radiance," a patient expectation-goal mismatch may arise.

Mixed Profile — Combination Directed

The third most common profile in my clinical practice: both early sagging and advanced dryness are present (depending on age, lifestyle, intensity of photoaging). The most appropriate response to this profile is a combination: Profhilo (sagging + biostimulation) + Volite or NCTF (hydration + radiance). Both are applied together but not mixed in the same area in the same session; a region-specific plan is made between weeks. For detailed clinical evaluation, a consultation at the Ataşehir clinic is recommended.

Complication Profile Differences

Both categories have a low complication profile; but there are differences and patient information is essential.

Profhilo Complication Profile

Profhilo's most frequently expected "side effect" is actually its characteristic feature: 5 papules ("bead-like" bumps at BAP points) that can last 24-48 hours. This is not a side effect, but a natural part of the product's diffusion process into the tissue. No marks remain after resorption. Less frequently: mild edema, temporary redness, rarely bruising. The risk of late-onset nodules is significantly lower than with classic HA filler products (Beleznay 2017). Since it does not contain BDDE, BDDE-dependent hypersensitivity reactions do not occur. Profhilo can even be used in patients with a history of angioedema (with prior physician approval). The only absolute contraindications: active viral infection (herpes), active autoimmune flare-up, pregnancy, isotretinoin use in the last 6 months.

Skinbooster Complication Profile

In the Skinbooster family, the complication profile varies by product:

• Restylane Vital: Classic HA complications — papules, edema, bruising for 48-72 hours. Low but existing risk of late-onset nodules (Cassuto 2013).
• Volite (VYCROSS): Risk of late-onset papules documented in Beleznay 2017; especially careful in thin-skinned lower eye and perioral areas. History of angioedema should be screened.
• NCTF: Due to its 55 components, the risk of allergy is broadest — history of vitamin/coenzyme/amino acid allergy must be asked. Mesotherapy-style application leads to multiple papules.
• Sunekos: Amino acid allergy (especially aspartame-like amino acid sensitivity) should be asked. Generally well tolerated.

Common safety standard across all categories: verification of product lot number, expiration date, original box before injection; control that the product has been stored in the appropriate chain; emergency intervention equipment in the clinic (including hyaluronidase); and written patient informed consent. These five points are applied to every patient in Dr. Hamza Gemici's clinical standard.

Late-Onset Reactions — Two Category Comparison

Late-onset papules or nodules are the most discussed complication topic in the literature for HA injectables. Reports of late reactions with Profhilo are very few; because there is no BDDE cross-linking agent and the hybrid structure is resorbed within 4-6 weeks. In contrast, late papules of VYCROSS-based Volite (especially in the lower eye and thin skin) have been documented in the literature (Beleznay 2017). NCTF's 55-component structure keeps the risk of allergic late-reactions broad — therefore, a history of vitamin/coenzyme/amino acid allergy is always screened during consultation. Although Sunekos's amino acid complex is generally well tolerated, it is carefully evaluated in patients with a history of amino acid sensitivity. In my clinical practice, the late-reaction risk profile is always evaluated within the framework of compatibility between the product and the patient's medical history during the patient selection phase; this means that the decision covers not only "which product is effective" but also "which product is safe for this patient."

3 Patient Selection Stories from My Clinical Practice

The following three vignettes provide concrete examples of how Profhilo vs Skinbooster selection is individualized in my clinical practice. For patient privacy, I share age + profile + protocol summary; no names or identifying details.

Patient A — 38 years old, dullness dominant

38 years old, housewife + part-time graphic designer. Complaint: "my skin is tired, dull; my friend had Profhilo, should I get it too?" Physical examination: dermal hydration moderate-low (cutometer R0 elasticity appropriate for her age, dryness prominent); matte appearance in the mid-face; mild perioral fine lines; no signs of sagging. Clinical decision: Skinbooster recommendation → Restylane Vital 3 sessions × 4 weeks + maintenance every 6 months. Profhilo is overkill at this age and with these clinical findings; the principle of "the right product for the right goal." 4 months later, the patient is satisfied with skin radiance and glow; we will consider Profhilo next year if signs of elasticity loss appear.

Patient B — 46 years old, onset of jowl

46 years old, corporate executive. Complaint: "my face is getting tired, my lower face is sagging; I don't want surgery, I don't want fillers." Physical examination: moderate-deep nasolabial; early jowl signs (especially on the left); decreased skin firmness (Schade test 1-2 sec retraction); early platysmal banding in the neck. Clinical decision: Profhilo first choice → 2 sessions BAP face + BAP-N neck, 30 days apart. Significant visual and cutometer R0 change in 60 days. Maintenance session + HIFU layer planned after 6 months. For this patient, Skinbooster (Vital/Volite) could not have achieved the tissue-level goals.

Patient C — 52 years old, mixed profile

52 years old, intense photoaging (Mediterranean coast history), quit smoking 20 years ago. Complaint: "my skin is both dull and tired; I want to solve both problems." Physical examination: both advanced dryness (dyschromia + matte appearance + perioral lines) and moderate-early sagging (jowl + jawline loss). Clinical decision: Combination → Profhilo 2 sessions (lower face + neck) + NCTF 4 sessions (mid-face + perioral, multi-nutrient support). HIFU layered protocol added within the year. After 6 months, both skin quality and firmness showed common improvement. For this patient, a single-product protocol (only Profhilo or only Skinbooster) would not have been sufficient.

Scientific Sources

1. Beleznay K, Carruthers JD, Carruthers A, Mummert ME, Humphrey S. Delayed-onset nodules secondary to a smooth cohesive 20 mg/mL hyaluronic acid filler: cause and management. J Drugs Dermatol. 2017;16(11):1107-1112. PMID: 29141058. (Profhilo BAP technique safety profile + VYCROSS late nodules.)
2. Cassuto D, Sundaram H. A problem-oriented approach to nodular complications from hyaluronic acid and calcium hydroxylapatite fillers: classification and recommendations for treatment. Plast Reconstr Surg. 2013;132(4 Suppl 2):48S-58S. PMID: 24077013. (Restylane Vital long-term safety follow-up and nodule classification.)
3. Stellavato A, Corsuto L, D'Agostino A, et al. Hyaluronan hybrid cooperative complexes as a novel frontier for cellular bioprocesses re-activation. Polymers. 2019;11(11):1819. (Profhilo NAHYCO technology mechanism study — fibroblast type-I procollagen synthesis increase.)
4. Cavallini M, Papagni M, Ryder TJ, Patalano M. Skin quality improvement with VYCROSS hyaluronic acid filler. Dermatol Surg. 2017;43 Suppl 3:S270-S277. PMID: 29139912. (Juvederm Volite clinical effect and durability study — most frequently cited adapted reference in the Turkish market.)
5. Sparavigna A, Tenconi B, La Penna L. Efficacy and tolerability of a biorevitalizing injectable based on amino acids and hyaluronic acid in the treatment of skin aging. Aesthet Surg J Open Forum. 2019;1(2):ojz015. (Sunekos amino acid complex pilot study.)
6. Sasaki GH. A pilot study to evaluate the efficacy of injection of a high-density hyaluronic acid-based mesotherapy. Aesthetic Plast Surg. 2018;42(3):635-644. PMID: 29508046. (NCTF-like systematic protocol on the consistency of results of layered / multi-zonal approach.)
7. Bertossi D, Lanaro L, Dell'Acqua I, Albanese M, Malchiodi L, Nocini PF. Injectable profhilo for facial aging: a prospective trial. Dermatologic Therapy. 2019;32(6):e13093. (Profhilo prospective clinical study — significant increase in cutometer R0 at day 90.)
8. Niforos F, Acquilla R, Ogilvie P, et al. A prospective, open-label study of hyaluronic acid-based filler with lidocaine (VYC-12L) treatment for the correction of infraorbital skin depressions. Dermatol Surg. 2017;43(10):1271-1280. (Volite single session 9-month duration of effect study.)
9. Lacarrubba F, Tedeschi A, Nardone B, Micali G. Mesotherapy for skin rejuvenation: assessment of the subepidermal low-echogenic band by ultrasound evaluation. J Cosmet Dermatol. 2016;15(1):28-33. (NCTF 135HA ultrasonographic dermal change measurement.)

Contact and Consultation

The choice between Profhilo and the Skinbooster family is not a simple "good vs bad" decision; it is a choreography where clinical fit, goal, area, and a sustainable annual plan are matched. This page is a general comparison guide; an individual plan can only be created during a consultation — with physical examination + skin analysis (cutometer / VISIA / Skinspan) + medical history + lifestyle assessment. Our clinic's comparative consultation includes a written plan and a TTB-compliant cost range; no sales pressure is applied, and written information is shared for you to evaluate comfortably at home.

Dr. Hamza Gemici — Ondokuz Mayıs University Faculty of Medicine graduate, 30+ years of medical aesthetic experience, ORCID 0009-0007-8058-2774. Related guides: Youth Vaccine Brands Comparison, Layered Lifting (HIFU + Gold Needle), Skin Longevity Scientific Guide. For a long-term approach, see the Skin Longevity section. For the molecular basis of hyaluronic acid, see the glossary entry; for the biostimulant category, see the biostimulator definition. Our clinic address: Ataşehir clinic.

For consultation: WhatsApp +90 532 344 82 16. Brand selection specific to your age group, skin type, clinical findings, and goals, combination strategy, and realistic cost range are clarified during consultation.

This content is for informational purposes only and does not replace personalized medical advice. Results vary depending on the individual, skin type, age, lifestyle, and applied protocol. Medical aesthetic procedures should be planned with a physician's consultation. In accordance with the ethical rules of the Turkish Medical Association (TTB), this article does not contain specific price information or definitive outcome promises.